Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongyi Zeng

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Multifunctional Biomimetic Nanocarriers for Dual-Targeted Immuno-Gene Therapy Against Hepatocellular CarcinomaYupeng Sun, Yan Liu, Rui Li, et al.
Communications Biology|June 9, 2023
Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogelQiuyu Zhuang, Binyu Zhao, Zhiwen Lin, et al.
Journal for Immunotherapy of Cancer|December 31, 2025
Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunityZhixiong Cai, Kongying Lin, Xiuqing Dong, et al.
BJS Open|March 23, 2026
Liver resection versus transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombusBin Guo, Shaliheng Yerken, Chu Luo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 7, 2025
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implicationsBixing Zhao, Yang Zhou, Niangmei Cheng, et al.
Journal of Nanobiotechnology|April 29, 2026
Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapyJiyue Wang, Yongyi Liang, Wenxiang Qi, et al.
Therapeutic Advances in Medical Oncology|December 1, 2025
Treatment response and prediction model of radiotherapy for hepatocellular carcinoma with macrovascular tumor thrombus: a multicenter retrospective studyQizhen Huang, Jing Yang, Xiaohong Zhong, et al.
Theranostics|April 14, 2025
Two-plex <i>in vivo</i> molecular imaging in the second near-infrared window for immunotherapeutic responseYupeng Sun, Rui Li, Yike Cai, et al.
Cancer Medicine|November 1, 2023
Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter studyQizhen Huang, Kongying Lin, Zhipeng Lin, et al.
Molecular Cancer|December 14, 2021
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasionZhixiong Cai, Xiaoping Su, Liman Qiu, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Multifunctional Biomimetic Nanocarriers for Dual-Targeted Immuno-Gene Therapy Against Hepatocellular CarcinomaYupeng Sun, Yan Liu, Rui Li, et al.
Communications Biology|June 9, 2023
Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogelQiuyu Zhuang, Binyu Zhao, Zhiwen Lin, et al.
Journal for Immunotherapy of Cancer|December 31, 2025
Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunityZhixiong Cai, Kongying Lin, Xiuqing Dong, et al.
BJS Open|March 23, 2026
Liver resection versus transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombusBin Guo, Shaliheng Yerken, Chu Luo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 7, 2025
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implicationsBixing Zhao, Yang Zhou, Niangmei Cheng, et al.
Journal of Nanobiotechnology|April 29, 2026
Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapyJiyue Wang, Yongyi Liang, Wenxiang Qi, et al.
Therapeutic Advances in Medical Oncology|December 1, 2025
Treatment response and prediction model of radiotherapy for hepatocellular carcinoma with macrovascular tumor thrombus: a multicenter retrospective studyQizhen Huang, Jing Yang, Xiaohong Zhong, et al.
Theranostics|April 14, 2025
Two-plex <i>in vivo</i> molecular imaging in the second near-infrared window for immunotherapeutic responseYupeng Sun, Rui Li, Yike Cai, et al.
Cancer Medicine|November 1, 2023
Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter studyQizhen Huang, Kongying Lin, Zhipeng Lin, et al.
Molecular Cancer|December 14, 2021
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasionZhixiong Cai, Xiaoping Su, Liman Qiu, et al.
Pageof 20